BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24269900)

  • 21. Identification of differential phosphorylation and sub-cellular localization of the metastasis suppressor, NDRG1.
    Park KC; Menezes SV; Kalinowski DS; Sahni S; Jansson PJ; Kovacevic Z; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2644-2663. PubMed ID: 29679718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation.
    Pietiäinen V; Vassilev B; Blom T; Wang W; Nelson J; Bittman R; Bäck N; Zelcer N; Ikonen E
    J Cell Sci; 2013 Sep; 126(Pt 17):3961-71. PubMed ID: 23813961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-myc downstream regulated gene 1/Cap43 suppresses tumor growth and angiogenesis of pancreatic cancer through attenuation of inhibitor of kappaB kinase beta expression.
    Hosoi F; Izumi H; Kawahara A; Murakami Y; Kinoshita H; Kage M; Nishio K; Kohno K; Kuwano M; Ono M
    Cancer Res; 2009 Jun; 69(12):4983-91. PubMed ID: 19491262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
    Botham KM; Wheeler-Jones CP
    Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states.
    Ellen TP; Ke Q; Zhang P; Costa M
    Carcinogenesis; 2008 Jan; 29(1):2-8. PubMed ID: 17916902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.
    Tian S; Wang X; Proud CG
    Oncotarget; 2017 Jul; 8(28):46121-46135. PubMed ID: 28545025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anticancer effects of desferrioxamine on human breast adenocarcinoma and hepatocellular carcinoma cells.
    Salis O; Bedir A; Kilinc V; Alacam H; Gulten S; Okuyucu A
    Cancer Biomark; 2014; 14(6):419-26. PubMed ID: 25335733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3beta.
    Banz VM; Medová M; Keogh A; Furer C; Zimmer Y; Candinas D; Stroka D
    Biochim Biophys Acta; 2009 Oct; 1793(10):1597-603. PubMed ID: 19682504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer.
    Kovacevic Z; Chikhani S; Lovejoy DB; Richardson DR
    Mol Pharmacol; 2011 Oct; 80(4):598-609. PubMed ID: 21719465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time- and oxygen-dependent expression and regulation of NDRG1 in human brain cancer cells.
    Said HM; Safari R; Al-Kafaji G; Ernestus RI; Löhr M; Katzer A; Flentje M; Hagemann C
    Oncol Rep; 2017 Jun; 37(6):3625-3634. PubMed ID: 28498432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma.
    Geleta B; Park KC; Jansson PJ; Sahni S; Maleki S; Xu Z; Murakami T; Pajic M; Apte MV; Richardson DR; Kovacevic Z
    FASEB J; 2021 Feb; 35(2):e21347. PubMed ID: 33484481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
    Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J
    Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1.
    Geleta B; Tout FS; Lim SC; Sahni S; Jansson PJ; Apte MV; Richardson DR; Kovačević Ž
    J Biol Chem; 2022 Mar; 298(3):101608. PubMed ID: 35065073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NDRG1 suppresses basal and hypoxia-induced autophagy at both the initiation and degradation stages and sensitizes pancreatic cancer cells to lysosomal membrane permeabilization.
    Sahni S; Gillson J; Park KC; Chiang S; Leck LYW; Jansson PJ; Richardson DR
    Biochim Biophys Acta Gen Subj; 2020 Aug; 1864(8):129625. PubMed ID: 32335136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
    Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
    Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
    Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
    Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel thiosemicarbazones regulate the signal transducer and activator of transcription 3 (STAT3) pathway: inhibition of constitutive and interleukin 6-induced activation by iron depletion.
    Lui GY; Kovacevic Z; V Menezes S; Kalinowski DS; Merlot AM; Sahni S; Richardson DR
    Mol Pharmacol; 2015; 87(3):543-60. PubMed ID: 25561562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel VHL target genes and relationship to hypoxic response pathways.
    Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
    Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.